PLUS1
1.89
-0.18 (-8.7%)
-0.18 (-8.7%)
Upgrade to Real-Time
Afterhours
| Volume | 3,197,977 |
|
|||||
| News | - | ||||||
| Day High | 2.0797 | Low High |
|||||
| Day Low | 1.82 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Spero Therapeutics Inc | SPRO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.18 | -8.7% | 1.89 | 16:14:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.05 | 1.82 | 2.0797 | 1.875 | 2.07 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,623 | 3,197,977 | $ 1.96 | $ 6,268,258 | - | 0.6801 - 18.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:14:17 | formt | 356 | $ 1.89 | USD |
Period:
Draw Mode:
Spero Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 66.28M | 35.07M | 29.76M | $ 18.26M | $ - | -2.91 | -0.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.59M | 2.70% |
Spero Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.92 | 2.28 | 1.82 | 2.04 | 4,106,388 | -0.03 | -1.56% |
| 1 Month | 1.24 | 3.18 | 0.81 | 2.10 | 16,511,721 | 0.65 | 52.42% |
| 3 Months | 0.8295 | 3.18 | 0.6801 | 1.83 | 8,190,308 | 1.06 | 127.85% |
| 6 Months | 7.11 | 7.87 | 0.6801 | 1.83 | 4,211,731 | -5.22 | -73.42% |
| 1 Year | 17.32 | 18.35 | 0.6801 | 2.16 | 2,179,452 | -15.43 | -89.09% |
| 3 Years | 10.43 | 23.639 | 0.6801 | 3.96 | 845,837 | -8.54 | -81.88% |
| 5 Years | 13.25 | 23.639 | 0.6801 | 4.37 | 548,740 | -11.36 | -85.74% |
Spero Therapeutics Description
| Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital. |
